Savara (SVRA)
(Delayed Data from NSDQ)
$4.46 USD
-0.12 (-2.62%)
Updated Jul 26, 2024 04:00 PM ET
After-Market: $4.46 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth B Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
SVRA 4.46 -0.12(-2.62%)
Will SVRA be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for SVRA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SVRA
Zacks.com featured highlights include Savara, The LGL Group, and Harte Hanks
3 Top Breakout Stocks to Add to Your Portfolio Now
SVRA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Has Assertio (ASRT) Outpaced Other Medical Stocks This Year?
After Golden Cross, Savara Inc. (SVRA)'s Technical Outlook is Bright
Other News for SVRA
Biotech Alert: Searches spiking for these stocks today
Savara Announces Pricing of $100.0 Million Underwritten Offering of Common Stock
Savara prices ~$100M stock offering
Largest borrow rate increases among liquid names
Savara price target raised by $2 at Guggenheim, here's why